Trial Profile
Exploratory Study of FYU-981 for Hyperuricemia With or Without Gout (Phase II (IIa) Study)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Dotinurad (Primary)
- Indications Gout; Hyperuricaemia
- Focus Therapeutic Use
- Sponsors Fuji Yakuhin
- 30 Jan 2015 New trial record